| 摘要 |
The present invention relates to a glucocorticoid (GC) for use in the amelioration, treatment and/or prophylaxis of hepatic and/or gastroenterological adverse events caused by an EpCAMxCD3 bispecific antibody, wherein the administration of the GC is started prior to the administration of the EpCAMxCD3 bispecific antibody. Kits comprising a GC, an EpCAMxCD3 bispecific antibody and instructions for use indicating that the GC is to be employed for the treatment, amelioration and/or prophylaxis of hepatic and/or gastroenterological adverse events caused by said EpCAMxCD3 bispecific antibody in a patient, are also disclosed. |
